Skip to main content

Laura Lovett

By Laura Lovett | 01:54 pm | October 30, 2019
Senators Elizabeth Warren, Patty Murray and Tina Smith continued to express concerns about the PreCert's 'Excellence Appraisals,' De Novo pathway and real-wrold performance markers.  
By Laura Lovett | 05:10 pm | October 29, 2019
All of the life insurer’s members with Type 1 or Type 2 diabetes will have access to the service, which offers savings on premiums. 
By Laura Lovett | 04:10 pm | October 29, 2019
Modus Capital led the round with participation from 212 Capital, QSTP, Kasamar Holdings, Dharmendra Ghai, Innoway and other unnamed investors.
By Laura Lovett | 02:32 pm | October 29, 2019
This year, 42% of survey-takers reported using at least one digital health tracking tool. 
By Laura Lovett | 04:43 pm | October 28, 2019
First Trust Capital Partners led the round with participation from Sumitomo Corporation of Americas and Ziegler. 
By Laura Lovett | 03:34 pm | October 28, 2019
Aflac Corporate Ventures led the round with participation from NMC, Nippon Life Insurance Company, Susquehanna International Group, Sojitz Corporation, Zuellig Pharma and Silicon Valley Bank. 
By Laura Lovett | 01:03 pm | October 28, 2019
The integration will start with Livongo for Behavioral Health in January and expand to other areas. 
By Laura Lovett | 05:17 pm | October 25, 2019
Brazil's government is looking to help its startups grow globally through its StartOut Brasil program. 
By Laura Lovett | 04:28 pm | October 24, 2019
The Series B round was led by Greenoaks with participation from Threshold Ventures, CRV, GV and Kleiner Perkins. 
By Laura Lovett | 02:38 pm | October 24, 2019
A study published in the New England Journal of Medicine found that patients had an average of 2.6 more hours a day in their target glucose range compared to their peers using a sensor-augmented pump.